Search

Compugen Ltd

Закрыт

2.11 -1.86

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

2.02

Макс.

2.15

Ключевые показатели

By Trading Economics

Доход

663K

-7M

Продажи

426K

2.6M

P/E

Средняя по отрасли

6.079

47.946

Прибыль на акцию

-0.07

Рентабельность продаж

-269.254

Сотрудники

75

EBITDA

665K

-7M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+112.26% upside

Дивиденды

By Acuity

Следующий отчет о доходах

9 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-6.3M

219M

Предыдущая цена открытия

3.97

Предыдущая цена закрытия

2.11

Compugen Ltd График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

8 окт. 2026 г., 23:56 UTC

Southwest Gas Holdings Inc's shares were roughly flat in after-market trading, showing limited movement since Thursday's close within a narrow range.

8 окт. 2026 г., 23:56 UTC

Yum Brands Inc. is experiencing a decline in after-market trading, retracing to near the low end of its range following four consecutive higher daily closes.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

TE Connectivity PLC is trading modestly higher in after-market hours, supported by positive market sentiment following improved Medicare Advantage Star Ratings for Humana.

8 окт. 2026 г., 23:56 UTC

Dropbox Inc shares are trading slightly higher in after-market hours, rebounding from an initial dip since Thursday's close.

8 окт. 2026 г., 23:56 UTC

Fluor Corp's shares are trading lower in after-market hours, declining slightly since Thursday's close and remaining below its 20-day moving average.

8 окт. 2026 г., 23:56 UTC

T Rowe Price Group Inc's shares traded roughly flat in after-market hours, reflecting stable conditions with slight fluctuations around Thursday's close.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

Southside Bancshares Inc's shares were little changed in after-market trading, remaining below their 20-day moving average amid broader subdued performance.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

Peoples Bancorp Inc is trading slightly higher in after-market hours, moving in sympathy with Nicolet Bankshares, Inc, which has also gained ground.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

United Bankshares Inc is little changed in after-market trading, moving in sympathy with Nicolet Bankshares, which has seen a slight increase since the previous close.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

Hancock Whitney Corp is slightly higher in after-market hours following Nicolet Bankshares, Inc.'s earnings release, despite its price remaining little changed overall.

8 окт. 2026 г., 23:56 UTC

Stanley Black & Decker Inc shares are trading lower in after-market hours, retracing from earlier gains and nearing the lower end of their one-month trading range.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

Independent Bank Corp is little changed in after-market trading, moving in sympathy with Nicolet Bankshares, which has seen unusual activity.

8 окт. 2026 г., 23:56 UTC

Wyndham Hotels & Resorts Inc saw a modest rise in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

8 окт. 2026 г., 23:56 UTC

Novanta Inc shares are trading slightly higher in after-market hours, maintaining a flat position since Thursday's close, despite recent lower finishes.

8 окт. 2026 г., 23:56 UTC

Correlated Moves

NBT Bancorp Inc is trading higher in after-market hours, moving in sympathy with Nicolet Bankshares, which has also gained ground.

8 окт. 2026 г., 23:55 UTC

New Jersey Resources Corp is trading higher in after-market hours, recovering from an early decline, though still below its 20-day moving average.

8 окт. 2026 г., 23:55 UTC

Match Group Inc shares are trading modestly lower in after-market hours, continuing a trend seen in earlier sessions despite recent gains in the previous three trading days.

8 окт. 2026 г., 23:55 UTC

Monster Beverage Corp shares are trading modestly higher in after-market hours, maintaining an upward trend since Thursday's close and staying above its 20-day moving average.

8 окт. 2026 г., 23:55 UTC

Coastal Financial Corp is trading higher in after-market hours, recovering from earlier lows.

8 окт. 2026 г., 23:55 UTC

Geo Group Inc shares have drifted lower during after-market trading, retracing from an early peak and settling in the middle of their one-month trading range.

8 окт. 2026 г., 23:55 UTC

Wix.Com Ltd's shares traded roughly flat during after-market hours, showing a slight upward drift from earlier negative territory, remaining below its 20-day moving average.

8 окт. 2026 г., 23:55 UTC

Motorola Solutions Inc. is trading higher in after-market hours, though it remains below its 20-day moving average and near the lower end of its one-month range.

8 окт. 2026 г., 23:55 UTC

Enpro Inc's shares are trading higher in after-market hours, gaining slightly since Thursday's close amid a broader market trend of four consecutive lower sessions.

8 окт. 2026 г., 23:55 UTC

Azenta Inc shares are trading slightly higher in after-market hours, maintaining a position above the 20-day moving average following recent declines.

8 окт. 2026 г., 23:55 UTC

Crocs Inc shares are modestly higher in after-market hours, settling around recent levels after a sharp rise earlier in the session.

8 окт. 2026 г., 23:55 UTC

Advance Auto Parts Inc shares traded roughly flat during after-market hours, maintaining a narrow range since Thursday's close and positioned above its 20-day moving average.

8 окт. 2026 г., 23:55 UTC

Constellation Energy Corp is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

8 окт. 2026 г., 23:55 UTC

NNN REIT Inc has advanced modestly in after-market trading, recovering from an initial dip to close at its highest level of the session.

8 окт. 2026 г., 23:55 UTC

Pinnacle Financial Partners Inc is seeing a slight increase in after-market trading, gaining ground since Thursday's close while remaining near the lower end of its one-month range.

8 окт. 2026 г., 23:55 UTC

Lindsay Corp's shares are modestly higher in after-market trading, recovering from earlier lows while approaching the session's highest point.

Сравнение c конкурентами

Изменение цены

Compugen Ltd Прогноз

Целевая цена

By TipRanks

112.26% рост

Прогноз на 12 месяцев

Средняя 4.5 USD  112.26%

Максимум 6 USD

Минимум 4 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Compugen Ltd на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

4

Покупка

0

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.